checkAd
    Startseite > Aktien > BIOSENIC > Nachrichten
    BIOSENIC Aktie
    0,0143
     
    EUR
    -0,70 %
    -0,0001 EUR
    Letzter Kurs 14.05.24 Lang & Schwarz
    0,0061
     
    EUR
    37.807 STK
    Geldkurs 14.05.24
    0,0224
     
    EUR
    37.807 STK
    Briefkurs 14.05.24
    ISIN: BE0974280126 · WKN: A14NHV · Belgien

    Neueste Nachrichten

    BioSenic S.A.: Information on the total number of voting rights and shares
    30.04.24 · globenewswire · BIOSENIC
    BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles
    26.04.24 · globenewswire · BIOSENIC
    BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023
    24.04.24 · globenewswire · BIOSENIC
    BioSenic S.A.: Transparency notifications received from François Rieger
    18.04.24 · globenewswire · BIOSENIC
    BioSenic provides further information on its restructuring plan
    12.04.24 · globenewswire · BIOSENIC
    BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of Nivelles
    11.04.24 · globenewswire · BIOSENIC
    BioSenic S.A.: Information on the total number of voting rights and shares
    29.03.24 · globenewswire · BIOSENIC
    BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World Congress
    20.03.24 · globenewswire · BIOSENIC
    BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease
    12.03.24 · globenewswire · BIOSENIC
    BioSenic S.A.: Information on the total number of voting rights and shares
    29.02.24 · globenewswire · BIOSENIC
    BioSenic raises €500,000 in private placement of new shares with established new investors
    02.02.24 · globenewswire · BIOSENIC
    BioSenic provides support to forthcoming European conference on graft-versus-host disease  
    31.01.24 · globenewswire · BIOSENIC